{"product_id":"heart-failure-isbn-9781405152587","title":"Heart Failure","description":"When you're considering device therapy for a patient with heart failure, be sure to consult this concise reference for the latest information on who benefits most from which device.  \u003cp\u003eIn clear, straightforward prose, Dr. Feldman addresses:\u003c\/p\u003e \u003cul\u003e \u003cli\u003eResynchronization Therapy\u003c\/li\u003e \u003cli\u003eICD\u003c\/li\u003e \u003cli\u003eUltrafiltration\u003c\/li\u003e \u003cli\u003eImpulse Therapy\u003c\/li\u003e \u003cli\u003eChronic Implantable Monitoring\u003c\/li\u003e \u003cli\u003eBioimpedance\u003c\/li\u003e \u003cli\u003eEECP\u003c\/li\u003e \u003cli\u003eand more\u003c\/li\u003e \u003c\/ul\u003e \u003cp\u003eWith chapters devoted to monitoring the patient on device therapy and the future of device therapy in heart failure, this book makes an important contribution to patient care.\u003c\/p\u003e  Contributor list.  \u003cp\u003ePreface.\u003c\/p\u003e \u003cp\u003eChapter One: Cardiac Resynchronization Therapy (\u003ci\u003eBehzad Pavri and Arthur M. Feldman\u003c\/i\u003e).\u003c\/p\u003e \u003cp\u003eChapter Two: Implantable Cardioverter-Defibrillator Therapy (\u003ci\u003eReginald T. Ho and Arnold J.Greenspon\u003c\/i\u003e).\u003c\/p\u003e \u003cp\u003eChapter Three: Chronic Implantable Monitoring (\u003ci\u003eNisha Aggarwal and David J. Whellan\u003c\/i\u003e).\u003c\/p\u003e \u003cp\u003eChapter Four: Cardiac Contractility Modulation by Electrical Signals Applied During Absolute Refractory Period as a Treatment for Chronic Heart Failure (\u003ci\u003eDaniel Burkhoff, Hani N. Sabbah, Christian Butter, Yuval Mika and Martin Borggrefe\u003c\/i\u003e).\u003c\/p\u003e \u003cp\u003eChapter Five: Role of Cardiac Restraint Devices in the Treatment of Patients with Dilated Cardiomyopathy (\u003ci\u003eDouglas L. Mann\u003c\/i\u003e).\u003c\/p\u003e \u003cp\u003eChapter Six: The Role of Right Heart Catherization in Management of Patients with Heart Failure (\u003ci\u003eSandeep A. Kamath and Mark H. Drazner\u003c\/i\u003e).\u003c\/p\u003e \u003cp\u003eChapter Seven: Impedance Cardiography (\u003ci\u003eSunthosh V. Parvathaneni and Ileana L. Pina\u003c\/i\u003e).\u003c\/p\u003e \u003cp\u003eChapter Eight: The Use of Echocardiography in Evaluating the Heart Failure Patient and Response to Therapy (\u003ci\u003eJohn Gorscan III\u003c\/i\u003e).\u003c\/p\u003e \u003cp\u003eChapter Nine: Revascularization for Left Ventricular Dysfunction (\u003ci\u003eNicholas J. Ruggiero II, Thomas J. Kiernan, Juan M. Bernal and Igor F. Palacios\u003c\/i\u003e).\u003c\/p\u003e \u003cp\u003eChapter Ten: Minimally Invasive Treatment of Mitral Valve Disease (\u003ci\u003eAndra Popescu and Paul J. Mather\u003c\/i\u003e).\u003c\/p\u003e \u003cp\u003eChapter Eleven: Percutaneous Mechanical Assist Devices (\u003ci\u003eSuresh Mulukutla, Lawrence Schneider and Howard A. Cohen\u003c\/i\u003e).\u003c\/p\u003e \u003cp\u003eChapter Twelve: Left Ventricular Assist Devices for Acute and Chronic Heart Failure (\u003ci\u003eDaniel Marelli, Louis Stein, Abbas Ardehali\u003c\/i\u003e).\u003c\/p\u003e \u003cp\u003eChapter Thirteen: The Role of Enhanced External Counterpulsation (EECP) in Heart Failure Management (\u003ci\u003eMarc A. Silver and William E. Lawson\u003c\/i\u003e).\u003c\/p\u003e \u003cp\u003eChapter Fourteen: Ultrafiltration (\u003ci\u003eMaria Rosa Constanzo\u003c\/i\u003e).\u003c\/p\u003e \u003cp\u003eConclusion.\u003c\/p\u003e \u003cp\u003eIndex.\u003c\/p\u003e \u003cp\u003eConflict of Interest Table.\u003c\/p\u003e  \u003cb\u003eArthur M Feldman MD PhD\u003cbr\u003e \u003c\/b\u003eAfter receiving his B.A. degree from Gettysburg College, and M.S. and Ph.D. degrees from the University of Maryland, Dr. Feldman served as a post-doctoral fellow in physiology at the Johns Hopkins University School of Medicine. After completing his medical degree at the Louisiana State University School of Medicine, he returned to Johns Hopkins where he served as an intern, resident and cardiology fellow.\u003cbr\u003e After joining the faculty in 1985, he was named the Director of the Belfer Laboratory for Molecular Biology of Heart Failure and the Director of the Heart Failure Research Program at The Johns Hopkins University School of Medicine. In 2004 Dr. Feldman joined the faculty at the University of Pittsburgh School of Medicine as the Harry S. Tack Professor of Medicine, Chief of the Division of Cardiology, and Director of the Cardiovascular Institute of the UPMC Health System.\u003cbr\u003e In 2002, Dr. Feldman was named the Magee Professor of Medicine and Chairman of the Department of Medicine at Jefferson Medical College. He is a past President of the Heart Failure Society of America and of the Association of Professors of Cardiology. He has served on the editorial boards of many scientific journals and was elected to membership in organizations including Alpha Omega Alpha, the Association of University Cardiologists, the American Society for Clinical Investigation and the Association of American Physicians.\u003cbr\u003e He has published over 200 peer-reviewed articles. Dr. Feldman's research has focused on molecular and clinical aspects of heart failure. Most recently he has chaired the Steering Committees for the PEECH, EMOTE and WEAR-IT trials and co-chaired the COMPANION study.  When you're considering device therapy for a patient with heart failure, be sure to consult this concise reference for the latest information on who benefits most from which device.  \u003cp\u003eIn clear, straightforward prose, Dr. Feldman addresses:\u003c\/p\u003e \u003cul\u003e \u003cli\u003eResynchronization Therapy\u003c\/li\u003e \u003cli\u003eICD\u003c\/li\u003e \u003cli\u003eUltrafiltration\u003c\/li\u003e \u003cli\u003eImpulse Therapy\u003c\/li\u003e \u003cli\u003eChronic Implantable Monitoring\u003c\/li\u003e \u003cli\u003eBioimpedance\u003c\/li\u003e \u003cli\u003eEECP\u003c\/li\u003e \u003cli\u003eand more\u003c\/li\u003e \u003c\/ul\u003e \u003cp\u003eWith chapters devoted to monitoring the patient on device therapy and the future of device therapy in heart failure, this book makes an important contribution to patient care.\u003c\/p\u003e","brand":"Wiley-Blackwell","offers":[{"title":"Default Title","offer_id":47989353447653,"sku":"NP9781405152587","price":119.95,"currency_code":"USD","in_stock":false}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/1842\/7735\/files\/9781405152587.jpg?v=1761783783","url":"https:\/\/k12savings.com\/products\/heart-failure-isbn-9781405152587","provider":"K12savings","version":"1.0","type":"link"}